EUVIMEDEUVIMED entdecken
Open Access

In the era of outpatient ventricular assist devices, is it time to reconsider the practice of bridging older children to transplant on outpatient inotropes?

Amalia Guzman-Gomez, Jason W Greenberg, Alia Dani, Chet Villa, Angela Lorts, Katerina Boucek, Farhan Zafar, David L S Morales

The Journal of Thoracic and Cardiovascular Surgery · 2024

DOI: 10.1016/j.jtcvs.2023.06.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2024. Verfasst von Amalia Guzman-Gomez und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cincinnati Children's Hospital Medical Center, The Heart Institute, University of Cincinnati College of Medicine, Cincinnati, Ohio. Hauptthemen laut MEDLINE: Heart-Assist Devices, Heart Transplantation, Cardiotonic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Ventricular assist devices (VADs) and inotropes are feasible modalities to bridge children to heart transplant (HT) in outpatient settings. However, it is unclear which modality yields superior clinical status at HT and posttransplant survival. METHODS: The United Network for Organ Sharing was used to identify patients aged 18 years or younger, weighing >25 kg, from 2012 to 2022 who were outpatients at HT (n = 835). Patients were grouped by bridging modality at HT: VAD (n = 235 [28%]), inotropes (n = 176 [21%]), or neither (no support) (n = 424 [50%]). RESULTS: VAD patients were of similar age (P = .260) but heavier (P = .007) and more likely to have dilated cardiomyopathy (P 70%) (59% vs 31%) (P < .001). Overall posttransplant survival in VAD patients (1-year and 5-year survival, 97% and 88%, respectively) was comparable to patients with no support (93% and 87%, respectively) (P = .090) and those on inotropes (98% and 83%, respectively) (P = .089). One-year conditional survival was superior for VAD vs inotrope (2-year and 6-year survival, 96% and 91%, respectively vs 97% and 79%, respectively) (P = .030) and 5-year conditional survival for VAD patients was superior to inotrope (7-year and 10-year survival, 100% and 100%, respectively vs 100% and 88%, respectively) (P = .022) and no support (100% and 83%, respectively) (P = .011). CONCLUSIONS: Consistent with prior studies, short-term outcomes for pediatric patients bridged to HT in the outpatient setting with VAD or inotropes is excellent. However, compared with outpatients bridged to HT on inotropes, outpatient VAD support allowed for better functional status at HT and superior late posttransplant survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart-Assist DevicesHeart TransplantationCardiotonic AgentsHumansChildMaleFemaleAdolescentChild, PreschoolInfantRetrospective StudiesAge FactorsTreatment OutcomeAmbulatory CareTime FactorsHeart FailureOutpatients

Stichwörter der Autor:innen

heart transplantationinotropesventricular assist device

Substanzen

Cardiotonic Agents

Autor:innen und Institutionen

  • Cincinnati Children's Hospital Medical Center, The Heart Institute, University of Cincinnati College of Medicine, Cincinnati, Ohio.
  • Cincinnati Children's Hospital Medical Center, The Heart Institute, University of Cincinnati College of Medicine, Cincinnati, Ohio. Electronic address: david.morales@cchmc.org.

Förderung

  • NHLBI NIH HHS
  • National Institutes of Health

Zitieren

APA

Guzman-Gomez, A., Greenberg, J. W., Dani, A., Villa, C., Lorts, A., Boucek, K., Zafar, F., & Morales, D. L. S. (2024). In the era of outpatient ventricular assist devices, is it time to reconsider the practice of bridging older children to transplant on outpatient inotropes?. The Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/j.jtcvs.2023.06.004

Vancouver

Guzman-Gomez A, Greenberg JW, Dani A, Villa C, Lorts A, Boucek K, et al. In the era of outpatient ventricular assist devices, is it time to reconsider the practice of bridging older children to transplant on outpatient inotropes?. The Journal of Thoracic and Cardiovascular Surgery. 2024. doi:10.1016/j.jtcvs.2023.06.004

BibTeX
@article{GuzmanGomez2024,
  author = {Guzman-Gomez, Amalia and Greenberg, Jason W and Dani, Alia and Villa, Chet and Lorts, Angela and Boucek, Katerina and Zafar, Farhan and Morales, David L S},
  title = {In the era of outpatient ventricular assist devices, is it time to reconsider the practice of bridging older children to transplant on outpatient inotropes?},
  journal = {The Journal of Thoracic and Cardiovascular Surgery},
  year = {2024},
  doi = {10.1016/j.jtcvs.2023.06.004}
}
Kostenlos starten →